Aytu Biopharma, Inc.
AYTU
$1.27
$0.010.79%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.24M | -6.25M | -15.84M | -13.68M | -18.00M |
| Total Depreciation and Amortization | 6.63M | 7.08M | 7.50M | 7.67M | 7.94M |
| Total Amortization of Deferred Charges | 652.00K | 778.00K | 899.00K | 861.00K | 861.00K |
| Total Other Non-Cash Items | -4.20M | 981.00K | 12.70M | 18.06M | 15.57M |
| Change in Net Operating Assets | 2.84M | -4.96M | -6.64M | -4.14M | -266.00K |
| Cash from Operations | 673.00K | -2.37M | -1.39M | 8.77M | 6.11M |
| Capital Expenditure | -142.00K | -136.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 668.00K | 517.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 5.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -79.00K | -253.00K | -329.00K | -450.00K | -409.00K |
| Cash from Investing | 447.00K | 128.00K | -329.00K | -450.00K | -404.00K |
| Total Debt Issued | 15.45M | 15.71M | 13.83M | -6.57M | -3.62M |
| Total Debt Repaid | -16.07M | -15.82M | -15.72M | -2.34M | -2.93M |
| Issuance of Common Stock | 3.38M | 3.47M | 3.47M | 2.65M | 4.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.01M | -975.00K | -2.84M | -1.47M | -3.23M |
| Cash from Financing | -251.00K | 2.38M | -1.26M | -7.73M | -5.68M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 869.00K | 144.00K | -2.98M | 581.00K | 28.00K |
